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Background: Assessment of stroke volume (SV) is often necessary in clinical and research settings. The clinically
established method for SV assessment in pregnancy is echocardiography, but given its limitations, it is not always
an appropriate measurement tool. Thoracic impedance cardiography (ICG) allows continuous, non-invasive SV
assessment. However, SV determination relies on assumptions regarding the thoracic shape that may mean the
algorithm is not valid in pregnancy. The available data regarding the validity of ICG against an established reference
standard using modern SV algorithms are both limited and conflicting. We aimed to test the validity of ICG in a
clinically realistic setting in late pregnancy using echocardiography.
Methods: Twenty-nine women in late pregnancy underwent standard echocardiography assessments with
simultaneous ICG measurement. Agreement between devices was tested using Bland-Altman analysis.
Results: Bland-Altman analysis of the relationship between ICG and echocardiography demonstrated that the 95%
limits of agreement exceeded acceptable or expected ranges. Measures of maternal and fetal anthropometry do
not account for the lack of agreement.
Conclusions: Absolute values of SV as determined by ICG are not valid in pregnancy. Further work is required to
examine the ability of ICG to assess relative changes in maternal haemodynamics in late pregnancy.
Keywords: Thoracic impedance cardiography, Pregnancy, Echocardiography, Stroke volume, Cardiac output,
Non-invasive assessmentBackground
The assessment and monitoring of stroke volume (SV)
and cardiac output (CO) is often useful in research and
for patient care. The currently established methods of
SV measurement have the disadvantage of being invasive
and carry a degree of risk to the participant (e.g. Fick
principle and thermodilution), or are minimally invasive,
but disruptive (e.g. echocardiography). In addition to re-
quiring specialist personnel, such methods are time-
consuming and continuous assessment is not always
possible. The use of invasive or disruptive methods in
assessment of healthy pregnant participants either pre-
sents unacceptable risk when not medically indicated, or* Correspondence: j.mcintyre@auckland.ac.nz
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unless otherwise stated.is not practical, especially if the intent is to monitor over
long periods of time, such as during sleep.
Echocardiography is clinically well established and
provides a detailed and accurate assessment of cardiac
structure and function in pregnancy. However, echo-
cardiography has its limitations. Results are highly
dependent on the skill of the echocardiographer [1],
and in pregnancy can be limited by patient position.
From a research perspective, echocardiography does not
provide a continuous assessment of cardiac function over
more than a few minutes and cannot be used in sleep
studies. Consequently, a non-invasive method that
permits continuous measurement, with less operator-
dependency that can be used in ambulatory settings
would be advantageous.
Thoracic impedance cardiography (ICG) may over-
come some of the disadvantages of the other methods.
ICG is a method of non-invasively estimating SV andal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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trodes, using complex algorithms to convert changes in
thoracic impedance into volume changes. ICG has the
potential to provide continuous (beat-to-beat) data
which is less operator-dependent and (potentially) less
influenced by patient factors such as body mass index
(BMI). However, the algorithms used by ICG to calculate
SV make assumptions regarding the thoracic dimensions
and shape, which it assumes to be a truncated cone [2].
This truncated cone model, and the assumption that all
patients have this thoracic shape, does not account for
the differing anthropometric profile contributions to any
increase in BMI (and therefore ignoring how it differs in
men and pregnant women). Smith [3] highlighted many
of the flaws to the assumptions made by ICG in an older,
but still very relevant, letter to the editor, including the
effect on impedance of the body size and shape, resistiv-
ity of blood and regional blood flow. Clearly, these are
important with the greatly differing shape and distribu-
tion of blood flow of the pregnant body. The published
data on ICG reliability and validity are inconclusive in a
non-pregnant population, and there is a paucity of pub-
lished data in a healthy late gestation pregnant popula-
tion. The few available studies on ICG performance in
pregnancy are inconsistent in their conclusions [4-9], in
part possibly due to most being reports based on older
equipment and algorithms, which have since been re-
vised. As a result, further validation of ICG in pregnancy
is required.
We aimed to examine the agreement between ICG




Healthy women aged ≥ 18 years with a normal singleton
pregnancy, late in the third trimester, were recruited
from low risk midwifery care. Exclusion criteria in-
cluded: smoking or alcohol use, any medical or obstetric
complications (e.g. intrauterine growth restriction, pre-
eclampsia, any known cardiovascular, respiratory or
renal disorders, all forms of diabetes), not regularly
attending scheduled obstetric appointments, ortho-
paedic or musculoskeletal conditions which would
make adopting different maternal positions difficult,
multiple pregnancy, and extremes of body habitus (i.e.
height <120 cm or >230 cm, weight <30 kg or >155 kg,
which have been reported to affect the accuracy of ICG
[10]). All participants were assessed by the study ob-
stetrician on the day of this study to ensure there were
no pregnancy abnormalities and an obstetric ultrasound
was performed to check fetal welfare. Birth outcome
data were collected to confirm the health status of the
fetus-neonate.Experimental design/protocol
All studies were performed under standardized condi-
tions in the afternoon. Participants were asked to abstain
from all caffeine containing foods, chocolate and strenu-
ous exercise on the day of study. Upon arrival, height
and weight were measured to determine current BMI and
body surface area (BSA). Self-reported pre-pregnancy
weight was obtained to determine pre-pregnancy BMI.
Participants then rested for 30 minutes prior to the assess-
ment during which time the electrodes were placed.
Echocardiography
Limited two-dimensional transthoracic echocardiograms
were performed by one qualified cardiac sonographer
using a Philips iE33 ultrasound machine (Bothell, WA,
USA). Patients were scanned in the left lateral decubitus
position. Standard transthoracic echocardiographic views
and measurements were acquired as per the recommen-
dations of the American Society of Echocardiography
guidelines [11,12], ensuring normality of cardiac anat-
omy and allowing for the measurement of left ventricu-
lar outflow tract velocity time integral (LVOTVTI) and
diameter (LVOTd) to calculate SV and CO.
During a period of stable cardiac rhythm, a Doppler
sample volume was placed within 1 cm of the aortic
valve in the LVOT and approximately 10 consecutive
beats were recorded in frozen screen format. This was
performed three times during the examination: begin-
ning (3.1 ± 1.3 minutes), mid-point (10.7 ± 2.3 minutes),
and end (17.5 ± 2.8 minutes) (these are termed epochs 1,
2 and 3, respectively in the results). CO was derived
from real-time measurements of three averaged con-
secutive cardiac cycles at each of the three time points.
Impedance cardiography
ICG data was collected continuously for the duration of
the echocardiography assessment. The CardioScreen 1000®
(Medis Medizinische Messtechnik GmbH, Ilmenau,
Germany) was attached to participants according to
manufacturer’s instructions using disposable adhesive
dual-surface electrodes in the lateral spot configuration,
after preparation with abrasive gel (Nuprep® Skin Prep Gel,
DO Weaver and Co., Aurora, CO, USA).
To allow direct comparison and synchronisation with
echocardiography, electronic markers were placed in the
ICG data at the first of each three averaged echocardiog-
raphy SV values, and one minute of ICG values were
averaged to give the SV value for that time point (30 sec-
onds either side of the echocardiography marker). As
the echocardiography computer only gave a time at
which the image was captured and the mean HR for that
captured image, and not an exact time for each RR inter-
val, it was not possible to compare the exact same car-
diac cycles between devices. Thirty seconds of ICG data
Table 1 Echo results, n = 29
Mean ± SD
LVOTd (cm) 2.1 ± 0.2
LVOT VTI (cm) 22.8 ± 3.9
LVOT Vmax (cm.s
−1) 116.0 ± 16.5
HR (bpm) 71.8 ± 11.7
SV (mL) 79.4 ± 19.7
CO (L.min−1) 5.6 ± 1.4
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best alternative, minimising any significant effects of any
potential outlier SV values if using a shorter time period.
The device used its own ECG signal to determine HR
and calculate CO from SV. SV was determined using the
in-built propriety PASA algorithm (Physiological Adaptive
Signal Analysis) [13], a modification of Sramek-Bernstein
algorithm [2].
The operators of the two different devices were
blinded to the values produced by the other during data
collection and retrospective analysis.
Data management
The relationship between ICG and echocardiography at
each epoch was analysed separately. Six velocity spec-
trums at each epoch were re-measured offline in a sub-
set of 20 participants to report intra-observer variability.
This was also used to test if the number of averaged car-
diac cycles, or whether “online” or “offline” analysis of
echocardiography waveforms (i.e. during or after the
echocardiogram), influenced echocardiography agree-
ment with ICG. The echocardiography coefficient of
variation (CoV) across the three epochs was compared
between averaging methods: mean of three beats per
epoch online vs. mean of three per epoch offline vs.
mean of six per epoch offline. For ICG, CoV was calcu-
lated using the 60 seconds of data at each of the three
epochs.
An analysis of variance (ANOVA) was used to test if
measures of HR, SV and CO changed significantly be-
tween epochs for each device. The agreement between
echocardiography and ICG values for SV and CO was
assessed for the full dataset using Bland-Altman ana-
lysis [14], with each epoch assessed separately, so as to
not violate the assumptions of independence between
samples [15]. In addition to absolute difference be-
tween devices, percentage error for each sample was
calculated as the absolute difference between echocar-
diography and ICG divided by the echocardiography
value, times 100.
The CoV across the three epochs was calculated from
the individual change in values between epochs and used
to compare the overall variance between devices.
Pearson correlation coefficients examined any rela-
tionship that maternal and fetal anatomical variables
might have with absolute SV and CO values and the
difference in ICG and echocardiography values.
We have used one outcome (CO) to calculate a
sample size of 30 subjects. This assumes a SD of CO
of 2.0 L/min. The cross over design makes it likely that
there will be a correlation between observations and if
we assume this to be 0.5, the difference detectable with
80% power at the 5% level of significance is 1.0 L/min,
which is of potential clinical significance.The Regional Human Ethics Committee approved the
study protocol (NTX/11/09/084), and all participants
provided written informed consent.
Results
Twenty-nine participants completed this study. Twenty-
one (72%) were Caucasian. Mean age was 30.5 ±
5.5 years, BMI: 28.8 ± 5.3 kg · m−2, and BSA: 1.9 ± 0.2 m2.
Pre-pregnancy BMI (23.4 ± 4.2 kg · m−2) was comparable
to that of the local obstetric population [16]. Twenty
(69%) were primigravid and 23 (79%) nulliparous.
Mean gestation was 37 weeks, estimated fetal weight
3062 ± 715 g, and deepest pool of amniotic fluid 5.5 ±
1.7 cm. Birth weight data was available to the researchers
on 27 of the new-borns. Gestation at birth was 40 ± 1 weeks
(n = 29) and birth weight 3469 ± 417 g (n = 27). All re-
ported live births, free of congenital abnormalities. The
echocardiogram assessment lasted 19.6 ± 4.1 minutes on
average.
Effect of number of cardiac cycles averaged on variability
of echocardiography
The CoVs for the three averaging methods were 6.7% for
the “online” measures, 7.5% when three offline measures
were averaged per epoch, and 10.4% for six offline mea-
sures at each epoch. This indicated that echocardiog-
raphy values have the lowest variation when measured
“online”, that is during the assessment, compared with
tracing the velocity spectrums retrospectively. Therefore,
the mean of three consecutive beats (online) was used in
all comparisons with ICG.
Echocardiographic results from healthy third trimester
pregnant women
All women had normal cardiac structure and function
(consistent with pregnancy) on the echocardiogram. The
echocardiographic measures of LVOT, HR, SV and CO
are shown in Table 1.
Echocardiographic assessment of participants and
validation of impedance cardiography
The mean and SD of HR, SV and CO for the echo and
ICG are presented in Table 2. Within-device differences
Table 2 Echo vs. ICG at epochs 1, 2 and 3
Echo ICG
HR (bpm)
1 71.4 ± 13.0 73.3 ± 11.9
2 71.8 ± 11.6 74.2 ± 11.7
3 72.5 ± 11.7 75.1 ± 13.0
SV (mL)
1 78.8 ± 19.1 85.8 ± 24.9
2 81.3 ± 21.4 81.9 ± 23.5
3 78.1 ± 18.5 81.6 ± 22.8
CO (L.min−1)
1 5.5 ± 1.3 6.2 ± 2.0
2 5.8 ± 1.7 6.0 ± 1.9
3 5.6 ± 1.2 6.1 ± 1.9
Mean ± SD (n = 29).
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reached statistical significance for echocardiography-
derived CO between epochs one and two (mean differ-
ence: −0.27 L.min−1, p = 0.04, 95% CI: −0.53 to −0.007).
The difference between echocardiography and ICG is
plotted against the average of the two values for each par-
ticipant in the Bland-Altman plots in Figure 1, with hori-
zontal lines indicating the mean difference ± 95% CI. The
mean difference (lower and upper limits of 95% CI)
for the three epochs was HR: −2.0 (−7.3, 3.4), −2.4
(−8.9, 4.1), −2.6 (−8.2, 3.0) bpm; SV: −7.0 (−55.8,
41.8), −0.6 (−44.5, 43.3), −3.5 (−40.6, 33.5) mL; CO: −0.7
(−4.4, 3.0), −0.3 (−3.5, 3.0), −0.5 (−3.2, 2.2) L.min−1. This
equated to a mean percentage error for the three epochs
of HR: 3.7 (−2.5, 9.9), 3.8 (−6.2, 13.8), 3.9 (−1.9, 9.7);
SV: 26.2 (−21.4, 73.8), 23.1 (−8.6, 54.8), 18.7 (−13.7,
51.1); CO: 29.2 (−19.3, 77.6), 24.2 (−10.5, 58.9), 20.1
(−14.4, 54.6). The mean HR for the 60s of ICG data
had excellent correlation with the echocardiography HR,
given as a mean value of all beats in the captured
image (R = 0.98, 0.96, 0.98 for epochs 1–3, respectively).
There was no correlation between maternal BMI, ma-
ternal BSA, estimated fetal weight or deepest pool of
amniotic fluid and the differences between ICG and echo-
cardiography SV or CO values at any epoch (r value
range: −0.33-0.17; p = 0.076-0.895). BMI demonstrated
a significant but marginal relationship with absolute
CO in all epochs with both devices, with absolute
HR in epochs one and two, but no significant corre-
lations with SV. BSA was significantly related with
both SV and CO in all epochs for both devices (r = 0.45-
0.70; p = 0.000-0.014), except for ICG-SV in epoch two
(r = 0.35; p = 0.061). Neither estimated fetal weight
nor deepest pool of amniotic fluid correlated with
CO or SV.The CoVs for the echocardiograms and the ICG based
in individual change across the three epochs are pre-
sented in Table 3. For both devices, the CoV for SV and
CO is comparable within devices. However, the CoV for
SV and CO values as determined by ICG are markedly
higher than the corresponding echocardiography values.
Discussion
In the current study, it was found that ICG and echocar-
diography have poor agreement in terms of SV and
hence CO determination. This study was designed to re-
flect a clinical environment, such that it could reason-
ably be expected to apply this protocol in the clinical
assessment of pregnant women. Conditions were stan-
dardized as far as was clinically reasonable, whilst per-
mitting optimal measurement of the cardiovascular
parameters being compared. The aim was to compare
the ICG with an established non-invasive method. Echo-
cardiography meets that criteria in both non-pregnant
[17] and pregnant populations [18].
Our LVOTVTI, HR, SV and CO values were compar-
able to published echocardiography values in similar ges-
tation women [19,20]. ICG-derived mean values for SV
and CO in the current paper were also comparable to
those previously published in similar gestation women
[21]. At 6.5 ± 2.5%, the echocardiography CoV in the
current study is lower than previously reported 8.8% for
cardiac output [22].
There was excellent correlation between echocardiog-
raphy and ICG derived HR, and clinically insignificant
differences between the devices in the Bland-Altman
analysis. Therefore, we can be confident that the HR
component of ICG is stable and accurate across the two
devices, and any discrepancies in CO can be attributed
to SV. The non-perfect correlation between ICG and
echocardiography-derived HR values (R = 0.96-0.98) can
be attributed to the different time periods (three con-
secutive cardiac cycles by echocardiography compared
with a continuous measure of 60 seconds of beat-beat
data from ICG). Ideally, the same three cardiac cycles
would be compared between the two devices, rather
than three beats versus 60 seconds of data. However, the
echocardiography gave an averaged, rather than instant-
aneous, heart rate, making such precise matches with
ICG impossible. As we were unable to synchronise beats
between echocardiography and ICG, a one minute
mean of ICG appeared to be the next best option.
Selecting fewer beats of ICG data would introduce a
potential for greater variability due to respiration if in-
deed different beats were selected to those analysed by
echocardiography. There was large variability in ICG
values compared with echocardiography (Table 3). This
may be due to the greater number of beats averaged in
each ICG sample compared with echocardiography
Figure 1 Bland-Altman plots; Echocardiography vs. Impedance Cardiography. Broken lines indicate mean ± 1.96 SD. HR, SV and CO are in
beats per minute, mL, and L.min−1, respectively.
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less stable and may account for a greater proportion
of the error between the two methods.
A much cited paper by Critchley and Critchley [23]
rightly states that any evaluation of CO measurement
devices should take into consideration the precision of
the reference method. They state that a previous review
had rejected CO measurement validation studies based
on percentage error that should have been accepted
when their adjusted limits of agreement of 30% were
used. Of note, one of the studies Critchley and Critchley
[23] re-categorised as satisfactory was validating echo-
cardiography against thermodilution, adding validity to
the reference standard used in the current study. A pre-
vious study [24] on the validity of different ultrasound
methods stated that echocardiography had a percentage
error of 10% based on earlier published data. If we were
to assume the same 10% error in our reference measure,Table 3 Coefficient of variations for Echo and ICG, n = 29
Echo ICG
HR 0.3 ± 1.4% (−2.4%, 3.0%) 7.7 ± 4.1% (−0.3%, 15.8%)
SV 6.7 ± 2.6% (1.6%, 11.9%) 19.3 ± 9.3% (1.2%, 37.5%)
CO 6.5 ± 2.5% (1.7%, 11.4%) 20.7 ± 9.4% (2.2%, 39.1%)
Mean CoV ± SD (95% Confidence Intervals).using the best percentage error (percent limits of
agreement) in the third epoch of approximately 20%
(14-55%), our results certainly fall outside of those
deemed acceptable in the error-gram of Critchley
and Critchley [23]. Even using the more conservative
20% precision (as used for thermodilution), our limits of
agreement still fall outside of the 30% limits of agreement
recommended by of Critchley and Critchley [23].
Burlingame et al. [4] compared echocardiography with
ICG in 28 women in late pregnancy (34.0 ± 1.2 weeks
gestation) when in the left lateral position. They used
the BioZ device with the ZMARC algorithm, which the
Medis ICG device and PASA algorithm are branded as
in some countries. They reported comparable values to
the current study, with SV of 74 ± 21 and 84 ± 24 mL,
and CO of 5.8 ± 1.6 and 6.4 ± 1.9 L.min−1, for echocardi-
ography and ICG respectively. However, the mean differ-
ence (confidence intervals) between the two devices at
15.1 mL (−29.1, 59.3) and 1.0 L.min−1 (−2.9, 4.9) for SV
and CO, respectively, was higher than the current
study, which ranged from −7.0 to −0.6 mL and −0.7
to −0.3 L.min−1. Interestingly, Burlingame et al. [4]
concluded that ICG was acceptable, even with these
wide confidence intervals.
Burlingame et al. [4] also reported that ICG was able
to detect subtle changes in SV when changing from
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the supine position using the reference method, echocar-
diography, but rather just noted the changes in ICG
values with position change. Therefore, whilst it can be
said that ICG can detect a change in SV with position,
the accuracy in the magnitude of change was not dem-
onstrated. The ability to detect changes in SV with ma-
ternal position is questionable, given that it has been
reported that ICG is only valid in lateral positions [9].
Using the ICG device NICCOMO (with the same manu-
facturers and SV algorithm as the device in the current
study), Tomsin et al. [25] cited moderate to high inter-
and intra-session reliability (Pearson’s Correlation
Coefficient) of various measures in uncomplicated
third trimester pregnancies in both supine and standing
positions. They did not report correlations between the
different positions, nor with another reference device.
Moertl et al. [17] investigated the ability of ICG to moni-
tor changes in SV in six assessments over the course of
pregnancy. They assessed individual components of a
modified version of the older Kubicek SV algorithm [26]
within a narrow range of RR-intervals in each of the par-
ticipants’ repeated assessments, as well as SV and CO.
They concluded that implausible and unreliable results
values were obtained, and that ICG appeared unsuitable
for monitoring changes in CO over pregnancy. One pre-
vious study reported that ICG-measured changes in SV
with position change in late pregnancy were of a magni-
tude with thermodilution [5]. This was however an older
study that used a different electrode configuration and
the first generation Kubicek algorithm [26].
Consideration of these unfavourable reports, along
with our own findings, does question the value of ICG
in late pregnancy. ICG produced SV and CO values that
were both greater and less than the corresponding echo-
cardiography values, resulting in large limits of agree-
ment (Figure 1). This indicates that absolute values
cannot be used. That the differences between ICG and
echocardiography did not correlate with maternal BMI
and BSA, estimated fetal weight (a surrogate for uterine
size) or deepest pool of amniotic fluid, indicate that
these variables cannot be held accountable for any differ-
ences in values between devices. The error is then likely
attributable to some flaw of either the ICG device or its
algorithm producing random error, or error of echocar-
diography, in this population.
The algorithms employed by ICG to calculate SV are
dependent on assumptions regarding the shape and di-
mensions of the thorax. The Sramek-Bernstein algorithm
[2] is one that many manufacturers incorporate into
their devices, or at least use propriety modifications of,
including the device used in this study. The Sramek-
Bernstein algorithm introduced a correction factor to ac-
count for deviations from an ideal BMI of 24 kg · m2 andtheir effects on the volume of electrical participating tis-
sue (VEPT) portion of the algorithm. It would not how-
ever account for the different body mass distribution
accounting for the increases in BMI in pregnant women
compared with males that it was tested in. Additionally,
it has been pointed out that the correction factor does
not account for possible effects of gender differences in
anthropometry on resistance to current, and thus ICG
outputs [27]. The differences in anatomy between men
and pregnant woman of similar BMI, such as thoracic
circumference and shape, and fat-lean mass ratio, may
mean that it is not appropriate to use the standard SV
algorithms in pregnancy. It has been observed that the
outputs from ICG are influenced by the sizes and posi-
tions of the electrodes, the patient’s body shape and size,
and “the resistivity of the blood and distribution of other
resistivities within the body” [3]. Highlighted also was
the non-uniformity of the current flow throughout the
whole of the thorax, whereby due to the electrode con-
figuration, outputs will be influenced greatly by small
volume flow changes in the neck, but less so by large
changes in the arms, for example. Finally, Smith [3]
described how the concept of ICG is using a simple
model to describe complex changes. This simple
model does not account for the potential effects on
impedance of uneven blood perfusion within the
thorax and the differing blood flow between heart and
rest of the body.
The changing thoracic anatomy, shape and fluid con-
tent with increasing gestation also mean that the algo-
rithms are unlikely to be able to be used to assess
differences in SV or CO at different gestations, consist-
ent with the findings of Moertl et al. [17]. The individual
anatomical variations in pregnancy would rule out any
ability to compare values between individuals, even at
similar gestations. An individual’s specific thoracic anat-
omy in pregnancy may even preclude comparison with
population norms, such as those reported by Morris
et al. [21]. A more likely utility of the ICG would be in
investigation of the physiological effects of an acute
intervention. This would depend on whether the differ-
ence between ICG and echocardiography we have ob-
served in the current study is due to a systematic error
of the ICG which remains constant over the course of
the intervention, thus providing a reliable measure of
relative change. The ability of ICG to accurately measure
relative changes in maternal haemodynamics in late
pregnancy would need to be demonstrated with a suit-
able reference measure. Using a device by the same
manufacturers (and therefore same algorithm), ICG
was reported to unreliably detect induced changes in
SV compared with echocardiography in healthy non-
pregnant participants [28]. In the current study, there
was no physiological challenge that may induce changes
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ity of ICG to detect those changes during the simultan-
eous measurement of echocardiography as Fellahi et al.
[28] did (and Secher et al. [26] using the older
algorithm). One method could be to test the effect of
maternal recumbent position change on SV as measured
by both devices. However, it is worth considering that
different maternal positions in late pregnancy can poten-
tially cause changes in thoracic geometry, which may in-
validate the algorithm, and potentially also change
maternal haemodynamics of a magnitude undetectable
by ICG. Additionally, echocardiography can only be used
effectively in late pregnancy (or indeed in most other sit-
uations) in a left lateral position. Previous work reported
that ICG in pregnancy has good agreement with echo-
cardiography only in the left and right lateral positions,
with poor agreement when the women were in supine,
sitting, standing or “knee-chest” positions [9]. This pre-
sents argument for a) changing fluid distribution with
differing positions influencing accuracy of SV algo-
rithms, b) the inability of ICG to accurately detect abso-
lute changes in SV, or c) a reduction of accuracy of the
reference standard, echocardiography, in non-lateral po-
sitions. Although Fellahi et al. [28] employed a different
protocol, including artificially-induced haemodynamic
load challenges, this demonstrates that the poor per-
formance of ICG, and this algorithm in particular, can-
not be attributed wholly to the pregnant condition of
our participants and would, in our opinion, remove the
need for a non-pregnant control group in the current
study. Given that Fellahi et al. [28] also employed echo-
cardiography as their reference measure, error associated
with echocardiography (in preference to ICG) however
cannot be discarded. A previous review reported a sig-
nificant effect (p = 0.03) of the reference method used on
how valid the ICG data was deemed to be [29]. Indirect
Fick studies had the highest correlation at r = 0.91, com-
pared with dye dilution (r = 0.82) and echocardiography
(r = 0.69). Of course, we cannot determine from these
studies if the error can be attributed to ICG or the refer-
ence standard. However, in the current study we only
assessed in the left lateral position, which is shown
to give the best agreement between ICG and echocardi-
ography [9], and the clinically accepted position for
accurate echocardiographic data. Therefore, we can be
confident that we minimised the error associated with
both position and the reference standard measure. The
utility of ICG to assess maternal physiology with pos-
ition changes remains to be proven.
Limitations
The assessment was standardised as much as possible
whilst not impeding on the echocardiography assess-
ment and in keeping it as realistic to clinical assessmentconditions as possible. However, it must be acknowl-
edged that the assessment was standardised firstly to
the echocardiography, in that it was designed to reflect
a normal echocardiography assessment of cardiovascu-
lar function, and secondly to have the most robust ICG
outputs possible. Participants were encouraged not to
talk during SV measurement (and during the corre-
sponding 60s ICG sample periods) and were given no
instructions regarding breathing. This ensured the best
possible conditions, with spontaneous breathing only
and minimal effects of a variable respiratory rate (i.e.
due to occasional sighs etc.). Breathing may have been
standardised further by paced breathing, but it was felt
that this was artificial and not representative of the
conditions that ICG would be employed in (i.e. during
sleep), and it would have been difficult to find a uni-
form respiratory rate that suited all women. Variations
in respiratory rate and volume (e.g. due to an individual
sigh) is unlikely to have affected mean SV over the
60 second ICG sample period, and the echocardiog-
rapher ensured only “normal” breaths during echocardi-
ography SV measurement. Additionally, as pointed out
by Burlingame et al. [4], improvements have been made
in ICG signal analysis software to minimise the effects
of respiratory variations.
Employing echocardiography as a reference measure
may also be seen as a limitation. However, echocardiog-
raphy is a clinically accepted, safe and non-invasive
method of cardiovascular assessment in pregnancy. Pre-
vious published data has demonstrated the clinical valid-
ity of echocardiography, even with greater variability
demonstrated than in the current study [22].
Lastly, as highlighted above, the different sample pe-
riods is another potential limitation. One potential
method to improve agreement between devices may be
to measure the LVOTVTI continuously using echocardi-
ography for the whole 60 seconds of the ICG sample
period and retrospectively tracing around all the velocity
spectrums.
Conclusion
In conclusion, SV and CO as measured by ICG and
echocardiography in healthy late pregnancy demon-
strates a moderate relationship at best. The between-
device agreement as illustrated by the Bland-Altman
plots was poor throughout the assessment. Maternal or
fetal variations in body proportions or size do not appear
to account for the lack of agreement. We cannot cat-
egorically attribute all the error to the ICG and we
acknowledge that echocardiography may have some in-
herent error. However, given the poor agreement be-
tween ICG and this clinically accepted tool, we cannot
endorse the use of ICG to assess SV in a healthy
pregnant population. Our results do not conclusively
McIntyre et al. BMC Pregnancy and Childbirth  (2015) 15:70 Page 8 of 9prohibit the use of ICG in this population, but it is yet to
be proven that it can be used in this setting. Further work
must be done to examine the ability of ICG to assess
relative changes in maternal haemodynamics in late
pregnancy.
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